*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

HERCEPTIN SOLUTION FOR INJECTION (FOR SUBCUTANEOUS USE)

Trastuzumab hyaluronidase (SC formulation)
600 mg
Injection

ROA

Subcutaneous

Applicant Name

Roche Products Limited

NRN

A6-0481

Status

Active


ATC Code

L01FD01  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 1  

Product Description

4 RNW-BV-313463 HERCEPTIN SOLUTION FOR INJECTION (FOR SUBCUTANEOUS USE) TRASTUZUMAB Trastuzumab sc 600 mg, Recombinant human hyaluronidase (rHuPH20) 10 000 U, L-Histidine 1.95 mg, L-Histidine hydrochloride monohydrate 18.35 mg, a,a-Trehalose dihydrate 397.25 mg, L-Methionine 7.45 mg, Polysorbate 20 2.0 mg, Water q.s.2 to 5.0 mL A6-0481 Vaccines & Biologicals Biologics Imported Products 1*1 2/7/2023 ROCHE PRODUCTS LIMITED, 2nd Floor, 48/50 Isaac John Street Ikeja GRA, Lagos. 8056292219 angela.essien@roche.com F. Hoffmann La Roche Ltd, Wurmisweg 4303, Kaiseraugst Switzerland., F. Hoffmann La Roche Ltd, Wurmisweg 4303, Kaiseraugst Switzerland., Switzerland

Manufacturer Name

F Hoffman La-Roche Ltd

Manufacturer Country

SWITZERLAND  

Approval Date

2023-07-03  

Expiry Date

2028-07-02